As antipsychotic use appears to backslide among nursing home residents, risks mount
By
Kimberly Marselas
Oct 11, 2021
For more than a decade, patient advocates and federal regulators have called for a reduction in nursing homes’ use of antipsychotic medications, a class of drugs once widely associated with controlling...
With scope unknown, nursing homes brace for new schizophrenia audits
By
Kimberly Marselas
Feb 10, 2023
Three weeks after federal officials announced they would begin auditing nursing homes for overuse of schizophrenia diagnoses, providers are still looking for answers about what those investigations will...